Juli Liu
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- Ginseng Biological Effects and Applications
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- Pluripotent Stem Cells Research 3
- RNA modifications and cancer 3
- CRISPR and Genetic Engineering 3
- Ginseng Biological Effects and Applications 2
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 2
- Co-authors
- Xi‐Yong Yu (5 shared papers)Lei Yang (9 shared papers)Liping Mai (4 shared papers)Qiu‐Xiong Lin (4 shared papers)Jie-Ning Zhu (4 shared papers)Xiaoying Liu (3 shared papers)Yong‐Heng Fu (2 shared papers)Zhi‐Xin Shan (3 shared papers)
- Journals
- Journal of Ethnopharmacology (2 papers)Biochemical and Biophysical Research Communications (1 paper)The FASEB Journal (1 paper)Bioactive Materials (1 paper)Developmental Cell (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Juli Liu
24 papers receiving 666 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 203
- Molecular Biology 400
- Complementary and alternative medicine 43
- Infectious Diseases 88
- Sensory Systems 21
Countries citing papers authored by Juli Liu
This map shows the geographic impact of Juli Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juli Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juli Liu more than expected).
Fields of papers citing papers by Juli Liu
This network shows the impact of papers produced by Juli Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juli Liu. The network helps show where Juli Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Juli Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 185 | |
| 2 | 2011 | 97 | |
| 3 | 2017 | 54 | |
| 4 | 2009 | 45 | |
| 5 | 2020 | 44 | |
| 6 | 2020 | 37 | |
| 7 | 2020 | 31 | |
| 8 | 2012 | 27 | |
| 9 | 2015 | 22 | |
| 10 | 2020 | 19 | |
| 11 | 2021 | 16 | |
| 12 | 2014 | 15 | |
| 13 | 2014 | 15 | |
| 14 | 2023 | 14 | |
| 15 | 2021 | 13 | |
| 16 | 2010 | 10 | |
| 17 | 2023 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2024 | 4 | |
| 20 | Genetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2 | 2020 | 3 |
About Juli Liu
Juli Liu is a scholar working on Molecular Biology, Infectious Diseases, Cancer Research, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 669 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), MicroRNA in disease regulation (4 papers), Pluripotent Stem Cells Research (3 papers), RNA modifications and cancer (3 papers), CRISPR and Genetic Engineering (3 papers), Aortic aneurysm repair treatments (2 papers), Ginseng Biological Effects and Applications (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Cancer Research (203 citations), Molecular Biology (400 citations), Complementary and alternative medicine (43 citations), Infectious Diseases (88 citations) and Sensory Systems (21 citations). Juli Liu has collaborated with scholars based in China and United States. Frequent co-authors include Xi‐Yong Yu, Lei Yang, Liping Mai, Qiu‐Xiong Lin, Jie-Ning Zhu, Xiaoying Liu, Yong‐Heng Fu, Zhi‐Xin Shan, Lin Shu-guang and Chunyu Deng. Their work appears in journals such as Journal of Ethnopharmacology, Biochemical and Biophysical Research Communications, The FASEB Journal, Bioactive Materials and Developmental Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.